Karolinska University Hospital
karolinska.seLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
273
Active
43
Phase 3
13
Total enrollment
1,559,239
Pipeline matrix
Showing 21 of 21 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Carboplatin, paclitaxel | — | — | — | — | — | 1 | |
| Cisplatin, paclitaxel | — | — | — | — | — | 1 | |
| Oxaliplatin, calcium folinate, 5-fluorouracil | — | — | — | — | — | 1 | |
| dtEC→dtT | — | — | — | — | — | 1 | |
| FEC→T | — | — | — | — | — | 1 | |
| Docetaxel | — | — | — | — | — | 2 | |
| Cyclophosphamide | — | — | — | — | 2 | ||
| Azacitidine | — | — | — | — | — | 2 | |
| Trastuzumab deruxtecan | — | — | — | — | — | 1 | |
| Paclitaxel | — | — | — | — | — | 1 | |
| Carboplatin | — | — | — | — | — | 1 | |
| Trastuzumab | — | — | — | — | — | 1 | |
| Pertuzumab | — | — | — | — | — | 1 | |
| Ribociclib | — | — | — | — | — | 1 | |
| Letrozole | — | — | — | — | — | 1 | |
| Epirubicin | — | — | — | — | — | 1 | |
| 68Ga-FAPI-46 | — | — | — | — | — | 1 | |
| [177Lu]Lu-AKIR001 | — | — | — | — | — | 1 | |
| Bulevirtide | — | — | — | — | — | 1 | |
| Testosterone treatment | — | — | — | — | — | 1 | |
| Optimized Medical Therapy for Atrial Fibrillation | — | — | — | — | — | 1 |
Next readouts
- 2016-04
- 2024-06-30
- 2025-12-30
- 2026-12
- 2026-12-31
- 2027-04-30
- 2027-11-01
- 2031-11-01
- 2033-03
Top conditions
- Critical Illness11
- Breast Cancer7
- Anesthesia7
- Cystic Fibrosis6
- Aortic Valve Stenosis5
- Aortic Aneurysm5
- Surgery5
- Sepsis5
Frequently asked questions about Karolinska University Hospital
- How many clinical trials does Karolinska University Hospital have on ClinicalTrials.gov?
- Karolinska University Hospital is listed as the lead sponsor on 273 clinical trials in ClinicalTrials.gov, 43 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Karolinska University Hospital's trials are in Phase 3?
- 13 of Karolinska University Hospital's trials are in Phase 3, spread across 21 active drug programs.
- What therapeutic areas does Karolinska University Hospital focus on?
- Karolinska University Hospital's most-studied conditions on ClinicalTrials.gov are Critical Illness, Breast Cancer, Anesthesia, Cystic Fibrosis, Aortic Valve Stenosis.
- When are Karolinska University Hospital's next clinical trial readouts?
- Karolinska University Hospital has 9 upcoming primary-completion readouts tracked here; the soonest is “Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients”, expected around 2016-04.